| Title : Aliskiren and captopril improve cognitive deficits in poorly controlled STZ-induced diabetic rats via amelioration of the hippocampal P-ERK, GSK3beta, P-GSK3beta pathway - Youssef_2020_Toxicol.Appl.Pharmacol__114954 |
| Author(s) : Youssef MM , Abd El-Latif HA , El-Yamany MF , Georgy GS |
| Ref : Toxicol Appl Pharmacol , :114954 , 2020 |
| Abstract : Youssef_2020_Toxicol.Appl.Pharmacol__114954 |
| ESTHER : Youssef_2020_Toxicol.Appl.Pharmacol__114954 |
| PubMedSearch : Youssef_2020_Toxicol.Appl.Pharmacol__114954 |
| PubMedID: 32171570 |
Youssef MM, Abd El-Latif HA, El-Yamany MF, Georgy GS (2020)
Aliskiren and captopril improve cognitive deficits in poorly controlled STZ-induced diabetic rats via amelioration of the hippocampal P-ERK, GSK3beta, P-GSK3beta pathway
Toxicol Appl Pharmacol
:114954
Youssef MM, Abd El-Latif HA, El-Yamany MF, Georgy GS (2020)
Toxicol Appl Pharmacol
:114954